Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.
Portal Biotech has raised $37.1M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Portal Biotech's investors include British Business Bank, 8VC, Pillar VC, Earlybird Venture Capital, SCVC.
Portal Biotech is headquartered in London, United Kingdom.
Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.
Portal Biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Portal Biotech — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/portal-biotech. Accessed July 19, 2026.
VCBacked. (2025). Portal Biotech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/portal-biotech
{{cite web |title=Portal Biotech — Funding & Investors |url=https://www.vcbacked.co/company/portal-biotech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated